Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway.

Yazmín Karina Márquez-FloresElizdath Martínez-GaleroJosé Correa-BasurtoYudibeth Sixto-López Isabel VillegasMaría Á RosilloAna CárdenoCatalina Alarcón-de-la-Lastra

Published in: Pharmaceuticals (Basel, Switzerland) (2024)

generation, as well as the inhibition of the canonical inflammasome pathway, regulating NLRP3, and consequently decreasing IL-1β and IL-18 activation.

Keyphrases

signaling pathway
pi k akt
molecular docking
cancer therapy
oxidative stress
cell proliferation
nitric oxide